Form SC 13G/A PhaseBio Pharmaceuticals Filed by: Rock Springs Capital Management LP

More PHAS News

• PhaseBio Announces Dosing of First Patient in European Union as Part of REVERSE-IT Global Phase 3 Trial of Bentracimab for Reversal of Antiplatelet Effects of Ticagrelor
  Business Wire - 8:00 AM ET 01/28/2021
• BRIEF-PhaseBio Presents Data From Phase 1B/2A Trial Of Pemziviptadil To Treat Pulmonary Arterial Hypertension At Pulmonary Vascular Research Institute Virtual World Congress
  Reuters - 4:47 PM ET 01/27/2021
• PhaseBio Presents Data from Phase 1b/2a Trial of Pemziviptadil for the Treatment of Pulmonary Arterial Hypertension at 15th Pulmonary Vascular Research Institute Virtual World Congress
  Business Wire - 4:05 PM ET 01/27/2021